LifeSigns
PrivateLast Round
VC Round
May 11, 2026
Company Overview
LifeSigns is a health technology company that provides a wireless patient monitoring platform for hospitals, ambulances, and home care settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Telemedicine, EHR & EMR, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LifeSigns Comparables
Compare LifeSigns with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dozee | 85% | |
| BioIntelliSense | 83% | |
| VitalConnect | 81% | |
LifeSigns Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 11, 2026 | ||||
| Strategic | Feb 12, 2025 |
LifeSigns Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HealthQuad | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 12, 2025
Completed a strategic funding round.
- Nov 11, 2024
Grew 24% QoQ, from 116 to 144 employees.
LifeSigns Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LifeSigns's valuation, stock price, and market status.